The rationale was to develop recommendations on the use of 18 F-FDG PET in breast,
colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, …

Purpose: To compare luteinizing hormone-releasing hormone (LHRH) agonists with orchiectomy
or diethylstilbestrol, and to compare antiandrogens with any of these three alternatives. …

BACKGROUND The current systematic review and meta‐analysis compared monotherapy
and combined androgen blockade in the treatment of men with advanced prostate carcinoma…

… Samson, Daniel D. Von Hoff, and Mark R. Somerfield for the ASCO Working Group on
Chemotherapy Sensitivity and Resistance Assays … The Working Group wishes to express …

… Somerfield, Deborah Schrag, David Samson, Lawrence Holt, Debra Zelman, and Jaffer A.
Ajani … Oncology, Alexandria, VA; David Samson, Blue Cross Blue Shield Asso- …

Background Prostate cancer is the second leading cause of cancer death in men. Long
standing observations have found prostate cancer responsive to androgen suppression. The …

BACKGROUND The utility of procalcitonin to manage patients with infections is unclear. A
systematic review of comparative studies using procalcitonin‐guided antibiotic therapy in …

… Samson DJ , … Investigators: David J Samson, MS, Mark D Grant, MD, MPH, Thomas A
Ratko, PhD, Claudia J Bonnell, BSN, MLS, Kathleen M Ziegler, PharmD, and Naomi Aronson …

Diagnostic tests are critical components of effective health care. They help determine treatments
that are most beneficial for a given patient. Their assessment is a complex process that …

Over the past four decades, scientists have made substantial progress in understanding the
evolution of sleep patterns across the Tree of Life. Remarkably, the specifics of sleep along …